AI assistant
Sending…
WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2020
Feb 20, 2020
30339_dirs_2020-02-20_790c9066-0483-4ca1-b25a-8ccd18711e6d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2020-02-18
Reporting Person: Lai Quintin J (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-02-18 | Common Stock | A | 1013.00 | $173.22 | Acquired | 2233.8424 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-02-18 | Stock Options (Right to Buy) | $173.22 | A | 4464.00 | Acquired | 2030-02-18 | Common Stock (4464.00) | Direct |
Footnotes
F1: 2017 PSUs (PP16) award vesting.
F2: This award vests in four equal annual installments beginning on February 18, 2021.
More from WEST PHARMACEUTICAL SERVICES INC
Board/Management Information
2026
Jun 1
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 11
Declaration of Voting Results & Voting Rights Announcements
2026
May 5
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Interim / Quarterly Report
2026
Apr 23
Earnings Release
2026
Apr 23
Major Shareholding Notification
2026
Mar 27